Deletion analysis and clinical correlations in patients with Xp21 linked muscular dystrophy

被引:0
|
作者
Ülgenalp, A [1 ]
Giray, Ö
Bora, E
Hizli, T
Kurul, S
Sagin-Saylam, G
Karasoy, H
Uran, N
Dizdarer, G
Tütüncüoglu, S
Dirik, E
Özkinay, F
Erçal, D
机构
[1] Dokuz Eylul Univ, Fac Med, Dept Pediat, Izmir, Turkey
[2] Behcet Uz Childrens Hosp, Dept Neurol, Izmir, Turkey
[3] Behcet Uz Childrens Hosp, Dept Pediat, Izmir, Turkey
[4] Ege Univ, Fac Med, Izmir, Turkey
[5] Social Secur Tepecik Teaching Hosp, Izmir, Turkey
关键词
dystrophinopathy; deletion analysis; clinical correlation; gene promoter mutation;
D O I
暂无
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
We carried out molecular deletion analysis on 142 patients with Duchenne/Becker muscular dystrophy which covered 25 exons of the dystrophin gene. We also evaluated the results by comparing with the clinical findings and examples in the literature. A deletion ratio of 63.7% was achieved. Exon 46 was the most frequently affected region. Interestingly we also observed four cases with muscle promoter (Mp) region deletions which have been rarely reported in the literature.
引用
收藏
页码:333 / 338
页数:6
相关论文
共 50 条
  • [1] GENETIC AND CLINICAL CORRELATIONS OF XP21 MUSCULAR-DYSTROPHY
    BUSHBY, KMD
    JOURNAL OF INHERITED METABOLIC DISEASE, 1992, 15 (04) : 551 - 564
  • [2] Correlation of laboratory and clinical findings with the location of Xp21 deletion in Duchenne muscular dystrophy
    Tasdemir, HA
    Topaloglu, H
    Dincer, P
    Gogus, S
    Kotiloglu, E
    Ozdirim, E
    Yalaz, K
    TURKISH JOURNAL OF PEDIATRICS, 1997, 39 (03) : 317 - 324
  • [3] Xp21 deletion involving Duchenne muscular dystrophy and glycerol kinase loci
    Baric, I
    Sarnavka, V
    Lasan, R
    Fumic, K
    Maradin, M
    Sertic, J
    Begovic, D
    EUROPEAN JOURNAL OF HUMAN GENETICS, 1998, 6 : 65 - 65
  • [4] LOCALIZATION AND CLONING OF XP21 DELETION BREAKPOINTS INVOLVED IN MUSCULAR-DYSTROPHY
    MONACO, AP
    BERTELSON, CJ
    COLLETTIFEENER, C
    KUNKEL, LM
    HUMAN GENETICS, 1987, 75 (03) : 221 - 227
  • [5] DNA STUDIES IN A FAMILY WITH DUCHENNE MUSCULAR-DYSTROPHY AND A DELETION AT XP21
    GREENBERG, CR
    HAMERTON, JL
    NIGLI, M
    WROGEMANN, K
    AMERICAN JOURNAL OF HUMAN GENETICS, 1987, 41 (02) : 128 - 137
  • [6] Pseudohypertrophy of the temporalis muscle in Xp21 muscular dystrophy
    Richards, P
    Saywell, WR
    Heywood, P
    DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2000, 42 (11): : 786 - 787
  • [7] Xp21 muscular dystrophy due to X chromosome inversion
    Baxter, PS
    Maltby, EL
    Quarrell, O
    NEUROLOGY, 1997, 49 (01) : 260 - 260
  • [8] INTEGRATED STUDY OF 100 PATIENTS WITH XP21 LINKED MUSCULAR-DYSTROPHY USING CLINICAL, GENETIC, IMMUNOCHEMICAL, AND HISTOPATHOLOGICAL DATA .2. CORRELATIONS WITHIN INDIVIDUAL PATIENTS
    NICHOLSON, LVB
    JOHNSON, MA
    BUSHBY, KMD
    GARDNERMEDWIN, D
    CURTIS, A
    GINJAAR, IB
    DENDUNNEN, JT
    WELCH, JL
    BUTLER, TJ
    BAKKER, E
    VANOMMEN, GJB
    HARRIS, JB
    JOURNAL OF MEDICAL GENETICS, 1993, 30 (09) : 737 - 744
  • [9] DUCHENNE MUSCULAR-DYSTROPHY DUE TO FAMILIAL XP21 DELETION DETECTABLE BY DNA ANALYSIS AND FLOW-CYTOMETRY
    WILCOX, DE
    COOKE, A
    COLGAN, J
    BOYD, E
    AITKEN, DA
    SINCLAIR, L
    GLASGOW, L
    STEPHENSON, JB
    FERGUSONSMITH, MA
    HUMAN GENETICS, 1986, 73 (02) : 175 - 180
  • [10] Xp21 Deletion Syndrome
    McCarron, L.
    Dunne, E.
    Moloney, S.
    McGrath, N.
    Lynch, S. A.
    Murphy, N. P.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2018, 187 : S189 - S189